31. SAT0616 Diagnostic modeling of systemic lupus erythematosus based on new and traditional autoantibodies- demonstration of feasibility. (15th June 2017) Authors: Budde, P; Zucht, H-D; Schulte-Pelkum, J; Wirtz, DS; Rengers, P; Witte, T; Schulz-Knappe, P; Schneider, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Issue 11 (19th November 2008) Authors: Abelson, A-K; Delgado-Vega, A M; Kozyrev, S V; Sánchez, E; Velázquez-Cruz, R; Eriksson, N; Wojcik, J; Linga Reddy, M V P; Lima, G; D'Alfonso, S; Migliaresi, S; Baca, V; Orozco, L; Witte, T; Ortego-Centeno, N; Abderrahim, H; Pons-Estel, B A; Gutiérrez, C; Suárez, A; González-Escribano, M F Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 11(2009) Page Start: 1746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. The Effect of Training on Stride Parameters in a Cohort of 40 Two Year Old Racehorses. (June 2014) Authors: Parkes, R; Pfau, T; Weller, R; Witte, T Journal: Equine veterinary journal Issue: Volume 46(2014)Supplement 46 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Issue 10 (17th October 2008) Authors: Kümpers, P; David, S; Haubitz, M; Hellpap, J; Horn, R; Bröcker, V; Schiffer, M; Haller, H; Witte, T Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 10(2009) Page Start: 1638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32). Issue 2 (8th June 2007) Authors: Werwitzke, S; Trick, D; Sondermann, P; Kamino, K; Schlegelberger, B; Kniesch, K; Tiede, A; Jacob, U; Schmidt, R E; Witte, T Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 2(2008) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗